In colorectal cancer, shikonin inhibited HIF-1α protein synthesis without affecting the expression of HIF-1α mRNA or degrading HIF-1α protein, which leads to inactivation of mTOR/p70S6K/4E-BP1/eIF4E [276]. The gene discussed is HIF1A; the disease is colorectal cancer.